Response to commentary by Dixon and Silman on the systematic review and meta-analysis by Bongartz et al.
Matteson
Eric L
EL
Bongartz
Tim
T
Sutton
Alex J
AJ
Buchan
Iain
I
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000453:epidemiology* / Q000628:therapy*; D006801:Humans; D007239:Infections / Q000453:epidemiology*; D015201:Meta-Analysis as Topic; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha